Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes

a stem cell and cardiomyocyte technology, applied in the field of cell culture articles, can solve the problems of immune response, hesc-based treatment development is hindered, biological products are vulnerable to batch variation, etc., and achieve the effects of improving shelf life, and reducing potential contamination issues

Inactive Publication Date: 2010-09-30
ASTERIAS BIOTHERAPEUTICS INC
View PDF23 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008]One or more of the various embodiments presented herein provide one or more advantages over prior surfaces for culturing stem cells, particularly undifferentiated stem cells. For example, the synthetic surfaces reduce potential contamination issues associated with surfaces having components obtained from or derived from animal sources. Such surfaces may also provide for improved shelf life compared to those surfaces with biological components. The ability to culture undifferentiated stem cells in chemically-defined media further reduces potential contamination issues. In addition, there will likely be less batch to batch variation in the performance capability of the synthetic surfaces or chemically defined media, resulting in improved reproducibility of culture results and expectations. These and other advantages will be readily understood from the following detailed descriptions when read in conjunction with the accompanying drawings

Problems solved by technology

However there remain obstacles in the development of such hESC-based treatments.
Such obstacles include obtaining and maintaining adequate numbers of undifferentiated hESCs in cell and tissue culture and controlling their differentiation in order to produce specific cell types.
These animal-derived additions to the culture environment expose the cells to potentially harmful viruses or other infectious agents which could be transferred to patients or compromise general culture and maintenance of the hESCs.
In addition, such biological products are vulnerable to batch variation, immune response and limited shelf-life.
While undifferentiated stem cells have been grown in chemically defined media on animal-derived surfaces such as MATRIGEL™ and proteins such as serum proteins or extra-cellular matrix proteins, to date, a completely animal product free system employing a chemically defined medium and a synthetic non-protein surface has not been identified for long-term culturing of undifferentiated stem cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes
  • Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes
  • Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes

Examples

Experimental program
Comparison scheme
Effect test

example 1

Coating Preparation

[0109]Swellable (meth)acrylate coating surfaces were prepared from UV polymerizable monomers and include a hydrophilic monomer, a carboxyl group containing monomer, and a crosslinking monomer. Table 1 shows the combination of swellable (meth)acrylate monomers employed. As shown in Table 1, formulations SA1A and SA1 have the same monomer composition. They differ from each other in that SA1A is diluted in ethanol in a 0.1% concentration v / v while SA1 is diluted in ethanol in a 0.25% v / v concentration or higher. The dilutions of monomers diluted in ethanol are shown in Table 3. Table 2 shows the chemical structures of the monomers used.

TABLE 1Swellable (meth)acrylate formulations employedCarboxyl groupFormulationHydrophilic MonomercontainingCrosslinkingNo.(vol. %)monomer (vol. %)monomer (vol. %)SA1A orhydroxyethyl2-carboxyethylTetra(ethyleneSA1methacrylate (80)acrylate (20)glycol)dimethacrylate (3)SA3hydroxyethyl2-carboxyethylTetra(ethylenemethacrylate (60)acrylate (...

example 2

Polypeptide Conjugation to Swellable (Meth)Acrylate Surface

[0113]In a series of experiments designed to evaluate polypeptide conjugation to the swellable (meth)acrylate coatings prepared as described above, a mixture of polypeptides (Ac-ArgGlyGlySerAspProlleTyrLys-NH2 (SEQ ID NO:3) / Rhod-GlyArgGlyAspSerProIleIleLys-NH2 (SEQ ID NO:4)) was conjugated to a swellable (meth)acrylate coating of Formulation SA1A (see Tables 1, 2 and 3) comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) / N-hydroxysuccinimide (NHS) chemistry. Briefly, 50 μL of 0.1 mM EDC and 0.05 mM NHS solution in DMF were dispensed into a well of 96-well cyclic olefin copolymer plate coated with swellable (meth)acrylate formulation. The activation of carboxyl groups was allowed to proceed for 1-1.5 h, and then the activating solution was aspirated. Immediately after that, 50 μL of polypeptide solution in 25 mM phosphate buffer pH 7.4 were dispensed into the well and the reaction between well surface...

example 3

HT-1080 Cell Adhesion and Proliferation Assays

[0117]To evaluate ability of a polypeptide conjugated to embodiments of swellable (meth)acrylate using these conjugation methods to enable cell adhesion and proliferation, peptides Ac-LysTyrGlyArgLysArgLeuGlnValGlnLeuSerlleArgThr-NH2 (SEQ ID NO:22) (AG-73, an adhesive peptide) and Ac—Ac-GlyArgGlyGluSerProIleTyrLys-NH2 (SEQ ID NO:30) (RGE, a negative control) were conjugated to swellable (meth)acrylate (as described above) and adhesion of HT-1080 human fibrosarcoma cells to the swellable (meth)acrylate was evaluated. Briefly, Laminin (5 μg / mL, Sigma-Aldrich) control wells were coated for 1 hour at room temperature. All wells were blocked with 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) for 1 hour at 37° C. Wells were washed briefly with PBS before incubation with 0.1% BSA in Iscove's Modified Dulbecco's Medium (IMDM) prior to cell seeding. HT-1080 human fibrosarcoma cells (ATCC number: CCL-121) were grown in IMDM (Lon...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Synthetic surfaces capable of supporting culture of eukaryotic cells including stem cells and undifferentiated human embryonic stem cells in a chemically defined medium include a swellable (meth)acrylate layer and a polypeptide conjugated to the swellable (meth)acrylate layer. The swellable (meth)acrylate layer may be formed by polymerizing monomers in a composition that includes a carboxyl group-containing (meth)acrylate monomer, a cross-linking (di- or higher-functional) (meth)acrylate monomer, and a hydrophilic monomer capable of polymerizing with the carboxyl group-containing (meth)acrylate monomer and the cross-linking (meth)acrylate monomer. The swellable (meth)acrylate layer has an equilibrium water content in water of between about 5% and about 70%. The conjugated peptide may include an RGD amino acid sequence.

Description

RELATED APPLICATION(S)[0001]This application claims the benefit of U.S. Provisional Application Ser. No. 61 / 062,890 filed Jan. 30, 2008 and entitled “Synthetic Surfaces for Culturing Undifferentiated Stem Cells in Chemically Defined Media” and U.S. Provisional Application Ser. No. 61 / 062,937 filed Jan. 30, 2008 and entitled “Stem Cell Article and Screening.”FIELD[0002]The present disclosure relates to cell culture articles, and more particularly to articles for supporting the culture of undifferentiated stem cells in a chemically defined medium.BACKGROUND[0003]Pluripotent stem cells such as human embryonic stem cells (hESCs) have the ability to differentiate into any of the three germ layers, giving rise to any adult cell type in the human body. This unique property provides a potential for developing new treatments for a number of serious cell degenerative diseases, such as diabetes, spinal chord injury, heart diseases and the like. However there remain obstacles in the development...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/0735
CPCC12N5/0068C12N5/0606C12N2537/10C12N2533/50C12N2533/30C12N5/0602
Inventor FADEEV, ANDREI GENNADYEVICHWEBER, JENNIFERMELKOUMIAN, ZARAWEBER, DAVID MICHAELZHOU, YUEBRANDENBERGER, RALPH
Owner ASTERIAS BIOTHERAPEUTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com